Lupin Ltd
NSE:LUPIN

Watchlist Manager
Lupin Ltd Logo
Lupin Ltd
NSE:LUPIN
Watchlist
Price: 2 085 INR 1.44%
Market Cap: 952.3B INR

Relative Value

The Relative Value of one LUPIN stock under the Base Case scenario is hidden INR. Compared to the current market price of 2 085 INR, Lupin Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LUPIN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
22
vs Industry
29
Median 3Y
3.7
Median 5Y
3
Industry
2.6
Forward
3.5
vs History
68
vs Industry
13
Median 3Y
37.7
Median 5Y
32.5
Industry
21.7
Forward
20.8
vs History
63
vs Industry
14
Median 3Y
20.3
Median 5Y
23.8
Industry
16.6
vs History
58
vs Industry
9
Median 3Y
62.3
Median 5Y
26.2
Industry
22.5
vs History
17
vs Industry
12
Median 3Y
5.2
Median 5Y
3.7
Industry
2.3
vs History
20
vs Industry
28
Median 3Y
3.7
Median 5Y
2.9
Industry
2.9
Forward
3.6
vs History
30
vs Industry
33
Median 3Y
5.4
Median 5Y
4.7
Industry
5.5
vs History
77
vs Industry
20
Median 3Y
18.9
Median 5Y
18.2
Industry
13.1
Forward
13.9
vs History
93
vs Industry
18
Median 3Y
28.3
Median 5Y
27.5
Industry
16.6
Forward
17
vs History
63
vs Industry
14
Median 3Y
20.6
Median 5Y
24.5
Industry
15.8
vs History
47
vs Industry
12
Median 3Y
37.9
Median 5Y
32.5
Industry
19.1
vs History
15
vs Industry
16
Median 3Y
3.9
Median 5Y
2.8
Industry
1.9

Multiples Across Competitors

LUPIN Competitors Multiples
Lupin Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Lupin Ltd
NSE:LUPIN
944.9B INR 3.8 22 15 18.8
US
Eli Lilly and Co
NYSE:LLY
939.8B USD 15.8 51 34.3 36.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
497B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
253.8B CHF 4.2 27.2 11.6 13.6
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP 4.8 29.8 108.8 159.3
CH
Novartis AG
SIX:NOVN
201.6B CHF 4.5 17.6 11.2 14.4
US
Merck & Co Inc
NYSE:MRK
242.8B USD 3.8 12.8 9.1 10.8
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13.2 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
146.6B USD 2.3 14.9 7.6 10.3
P/E Multiple
Earnings Growth PEG
IN
Lupin Ltd
NSE:LUPIN
Average P/E: 23.1
22
11%
2
US
Eli Lilly and Co
NYSE:LLY
51
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.2
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.8
38%
0.8
CH
Novartis AG
SIX:NOVN
17.6
17%
1
US
Merck & Co Inc
NYSE:MRK
12.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Lupin Ltd
NSE:LUPIN
Average EV/EBITDA: 399.1
15
9%
1.7
US
Eli Lilly and Co
NYSE:LLY
34.3
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.6
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.1
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Lupin Ltd
NSE:LUPIN
Average EV/EBIT: 1 709.4
18.8
10%
1.9
US
Eli Lilly and Co
NYSE:LLY
36.8
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.6
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
159.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.4
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.8
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
8%
1.3